Cite
HARVARD Citation
Ratnayake, G. et al. (2022). Blood T-cell profiling in metastatic melanoma patients as a marker for response to immune checkpoint inhibitors combined with radiotherapy. Radiotherapy and oncology. pp. 299-305. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ratnayake, G. et al. (2022). Blood T-cell profiling in metastatic melanoma patients as a marker for response to immune checkpoint inhibitors combined with radiotherapy. Radiotherapy and oncology. pp. 299-305. [Online].